Pharmafile Logo
Pharmafocus logo
Advanced Search

Sanofi

Showing 15 posts of 579 posts found.

UCB

Mixed Phase 3 results for Sanofi and UCB

July 29, 2015
Research and Development LixiLan, Sanofi, UCB, clinical trials, epratuzumab, insulin, insulin glargine, phase III

Two drugs that pharma companies are pinning hopes on for future success have had mixed outcomes in key late-stage clinical …

News
Regeneron building

Sanofi and Regeneron in immuno-oncology push

July 28, 2015
Manufacturing and Production, Research and Development Cancer, PD-1 inhibitors, Regeneron, Sanofi, collaboration, immuno-oncology, pd-1

Pharma giants Sanofi and Regeneron are extending the partnership that brought new heart drug Praluent to the market, with a …

News
Sanofi Regeneron

FDA and EMA approve heart drug Praluent

July 27, 2015
Sales and Marketing EMA, FDA, PCSK9, Regeneron, Sanofi, high cholesterol, praluent

The FDA and the EMA have both approved Sanofi and Regeneron’s new high cholesterol drug Praluent. Regulators on both sides …

News
brandicourt

New Sanofi boss Brandicourt restructures global business

July 16, 2015
Sales and Marketing Oliver Brandicourt, Sanofi

Sanofi is reorganising its pharmaceuticals division to create three new business units from January 2016. Chief executive Oliver Brandicourt has …

News
Logos

Praluent scores positive trial results in Japan

July 9, 2015
Research and Development Japan, PCKS9, Regeneron, Sanofi, heart disease, high cholesterol, praluent

Praluent, the new heart drug from Sanofi and Regeneron, has met its primary endpoint in a Phase III study in …

News
Sanofi Paris HQ

Sanofi’s Toujeo approved in Japan

July 3, 2015
Manufacturing and Production, Sales and Marketing Japan, Lantus Lantus XR, Sanofi, diabetes, toujeo, type diabetes

The Ministry of Health, Labor and Welfare in Japan has given Sanofi a marketing authorisation for the diabetes drug the …

News
screen_shot_2015-06-23_at_08

Former Sanofi chief executive joins Waypoint

June 23, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, Viehbacher, waypoint

The former Sanofi chief executive Christopher Viehbacher is joining Geneva-headquartered business enterprise firm Waypoint Capital as a managing partner.

Appointment

EU approval for new Sanofi, Merck vaccine

June 18, 2015
Sales and Marketing EU, Europe, Merck, Sanofi, Sanofi pasteur msd, brett wells, gardasil 9

Sanofi and Merck are looking forward to a successor to their blockbuster Gardasil now that the European Commission has granted …

News
Merkel image

Sanofi plays host to German chancellor Angela Merkel

May 29, 2015
Manufacturing and Production, Medical Communications, Sales and Marketing France, Germany, Sanofi, angela, brett wells, merkel

German Chancellor Dr Angela Merkel met with Sanofi bosses in Frankfurt to discuss antibiotics and open a new manufacturing facility. …

News
suresh_kumar

Sanofi appoints external affairs VP

May 27, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, suresh kumar

Sanofi has said Suresh Kumar is to join the French pharma giant on its executive committee and become executive vice …

Appointment
Jevtana image

Sanofi prostate cancer drug to remain on CDF

May 26, 2015
Sales and Marketing CDF, Cancer, NHS, Sanofi, list, prostate

Sanofi has reached an agreement with NHS England to reinstate its prostate cancer drug Jevtana on the Cancer Drugs Fund. …

News
Sanofi image

Sanofi’s rheumatoid arthritis biologic performs

May 22, 2015
Sales and Marketing Sanofi, rheumatoid arthritis, sarilumab

French pharma giant Sanofi plans to submit its new rheumatoid arthritis biologic for regulatory approval in the US after it …

News
Sanofi image

Sanofi sues decision aid maker for ‘injurious falsehood’

April 20, 2015
Medical Communications, Sales and Marketing Diagnosia, Sanofi, metamizole, tech

A tech start-up says it is being sued by pharma giant Sanofi for presenting facts about a drug’s side effects …

News
Rilutek (riluzole) image

Multiple sclerosis studies underway using existing drugs

April 2, 2015
Research and Development, Sales and Marketing MS, Midamor, Prozac, Rilutek, Sanofi, amiloride, covis, fluoxetine, multiple sclerosis, riluzole

Three existing drugs that fight heart disease, depression and motor neurone disease could be used to treat multiple sclerosis (MS) …

News
Sanofi image

Type 1 diabetes market value to double by 2023

March 19, 2015
Research and Development, Sales and Marketing GlobalData, NHS, NICE, Sanofi, diabetes, toujeo, type 1

The treatment market for type 1 diabetes is set to double to around $13.6 billion by 2023 according to analysts …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025